Your Health, We Care
Finerenone is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
来自FDA，2022.09
What is Finerenone?Finerenone contains the active ingredient Finerenone. This me···【more】
Release date：2026-05-06Recommended：70
Cardiovascular Effects of FinerenoneTwo large Phase III trials were conducted wi···【more】
Release date：2026-04-30Recommended：97
Mechanism of Action of FinerenoneFinerenone is indicated for the treatment of ad···【more】
Release date：2026-04-30Recommended：91
Finerenone is applicable to chronic kidney disease related to type 2 diabetes.【more】
Release date：2026-01-06Recommended：120
This article analyzes the clinical application and economic cost of finerenone.W···【more】
Release date：2025-04-15Recommended：256
According to the treatment needs of patients with specific chronic diseases, the···【more】
Release date：2025-04-15Recommended：239
In view of the application value and clinical practice of finerenone, this artic···【more】
Release date：2025-04-14Recommended：199
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
